×
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
NASDAQ:AFYA

Afya Stock Forecast, Price & News

$9.65
-0.28 (-2.82%)
(As of 07/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.36
$10.05
50-Day Range
$9.74
$15.11
52-Week Range
$9.36
$27.12
Volume
472,541 shs
Average Volume
294,502 shs
Market Capitalization
$888.46 million
P/E Ratio
19.30
Dividend Yield
N/A
Price Target
$22.83

Afya MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
136.9% Upside
$22.83 Price Target
Short Interest
Healthy
2.44% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
28.71%
From $1.01 to $1.30 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.18 out of 5 stars

Consumer Discretionary Sector

130th out of 406 stocks

Educational Services Industry

9th out of 51 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive AFYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Afya and its competitors with MarketBeat's FREE daily newsletter.

Afya logo

About Afya (NASDAQ:AFYA) Stock

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

AFYA Stock News Headlines

Contrasting Aspen Group (NASDAQ:ASPU) and Afya (NASDAQ:AFYA)
Is Afya (AFYA) a Great Value Stock Right Now?
Afya Limited Releases 2021 Sustainability Report
Afya (AFYA) Q1 Earnings Beat Estimates
Afya Limited Announces the Acquisition of Glic
Bertelsmann Completes Increase of Stake in Afya
See More Headlines

Industry, Sector and Symbol

Industry
Educational services
Sub-Industry
N/A
Current Symbol
NASDAQ:AFYA
Fax
N/A
Employees
8,079
Year Founded
N/A

Company Calendar

Last Earnings
5/23/2022
Today
7/05/2022
Next Earnings (Estimated)
8/25/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$22.83
High Stock Price Forecast
$28.50
Low Stock Price Forecast
$19.00
Forecasted Upside/Downside
+136.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.66666666666667
Research Coverage
3 Analysts

Profitability

Net Income
$41.38 million
Pretax Margin
15.98%

Debt

Sales & Book Value

Annual Sales
$318.68 million
Cash Flow
$0.74 per share
Book Value
$6.04 per share

Miscellaneous

Free Float
N/A
Market Cap
$888.46 million
Optionable
Not Optionable
Beta
1.15














Afya Frequently Asked Questions

Should I buy or sell Afya stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Afya in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Afya stock.
View analyst ratings for Afya
or view top-rated stocks.

What is Afya's stock price forecast for 2022?

3 brokerages have issued 12-month target prices for Afya's shares. Their AFYA stock forecasts range from $19.00 to $28.50. On average, they anticipate Afya's stock price to reach $22.83 in the next year. This suggests a possible upside of 136.6% from the stock's current price.
View analysts' price targets for Afya
or view top-rated stocks among Wall Street analysts.

How has Afya's stock performed in 2022?

Afya's stock was trading at $15.71 on January 1st, 2022. Since then, AFYA shares have decreased by 38.6% and is now trading at $9.65.
View the best growth stocks for 2022 here
.

When is Afya's next earnings date?

Afya is scheduled to release its next quarterly earnings announcement on Thursday, August 25th 2022.
View our earnings forecast for Afya
.

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) released its quarterly earnings results on Monday, May, 23rd. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.01. The business had revenue of $108.36 million for the quarter, compared to analysts' expectations of $111.84 million. Afya had a net margin of 13.03% and a trailing twelve-month return on equity of 8.07%. During the same quarter last year, the company earned $0.21 EPS.
View Afya's earnings history
.

What guidance has Afya issued on next quarter's earnings?

Afya updated its FY 2022 earnings guidance on Monday, June, 20th. The company provided EPS guidance of for the period. The company issued revenue guidance of $435.82 million-$451.11 million, compared to the consensus revenue estimate of $466.83 million.

Who are Afya's key executives?

Afya's management team includes the following people:
  • Mr. Virgilio Deloy Capobianco Gibbon, Chief Exec. Officer (Age 46)
  • Mr. Luis Andre Carpintero Blanco, Chief Financial Officer (Age 49)
  • Renata Couto, Investor Relations Exec. Mang.
  • Mr. Julio Eduardo Razente de Angeli, VP of Continuing Education & Innovation (Age 49)

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include (HON), Pfizer (PFE), Cisco Systems (CSCO), Procter & Gamble (PG), Raytheon Technologies (RTX), Abbott Laboratories (ABT), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA) and CSX (CSX).

When did Afya IPO?

(AFYA) raised $233 million in an initial public offering (IPO) on Friday, July 19th 2019. The company issued 13,700,000 shares at $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments served as the underwriters for the IPO.

What is Afya's stock symbol?

Afya trades on the NASDAQ under the ticker symbol "AFYA."

How do I buy shares of Afya?

Shares of AFYA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Afya's stock price today?

One share of AFYA stock can currently be purchased for approximately $9.65.

How much money does Afya make?

Afya (NASDAQ:AFYA) has a market capitalization of $888.46 million and generates $318.68 million in revenue each year. The company earns $41.38 million in net income (profit) each year or $0.50 on an earnings per share basis.

How many employees does Afya have?

Afya employs 8,079 workers across the globe.

How can I contact Afya?

Afya's mailing address is ALAMEDA OSCAR NIEMEYER NO 119 SALA 504 VILA DA SERRA, NOVA LIMA D5, . The official website for Afya is www.afya.com.br. The company can be reached via phone at 553135157550 or via email at ir@afya.com.

This page (NASDAQ:AFYA) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.